234 related articles for article (PubMed ID: 29870976)
1. Pathogenesis of Potassium-Competitive Acid Blocker-Resistant Non-Erosive Reflux Disease.
Kawami N; Hoshino S; Hoshikawa Y; Takenouchi N; Umezawa M; Hanada Y; Kaise M; Iwakiri K
Digestion; 2018; 98(3):194-200. PubMed ID: 29870976
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of Double-Dose Proton Pump Inhibitor-Resistant Non-Erosive Reflux Disease, and Mechanism of Reflux Symptoms and Gastric Acid Secretion-Suppressive Effect in the Presence or Absence of Helicobacter pylori Infection.
Kawami N; Takenouchi N; Umezawa M; Hoshino S; Hanada Y; Hoshikawa Y; Sano H; Hoshihara Y; Nomura T; Uchida E; Iwakiri K
Digestion; 2017; 95(2):140-145. PubMed ID: 28161707
[TBL] [Abstract][Full Text] [Related]
3. Determinants of reflux perception in patients with non-erosive reflux disease who have reflux-related symptoms on potassium-competitive acid blocker therapy.
Kawami N; Hoshino S; Hoshikawa Y; Tanabe T; Koeda M; Momma E; Takenouchi N; Hanada Y; Kaise M; Iwakiri K
Esophagus; 2022 Apr; 19(2):367-373. PubMed ID: 34655001
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
[TBL] [Abstract][Full Text] [Related]
6. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors.
Yamashita H; Kanamori A; Kano C; Hashimura H; Matsumoto K; Tsujimae M; Yoshizaki T; Momose K; Obata D; Eguchi T; Fujita M; Okada A
Digestion; 2017; 96(1):52-59. PubMed ID: 28662503
[TBL] [Abstract][Full Text] [Related]
8. Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure.
de Bortoli N; Martinucci I; Savarino E; Franchi R; Bertani L; Russo S; Ceccarelli L; Costa F; Bellini M; Blandizzi C; Savarino V; Marchi S
Dis Esophagus; 2016 Jan; 29(1):3-9. PubMed ID: 25212408
[TBL] [Abstract][Full Text] [Related]
9. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].
Soto Pérez JC; Icaza ME; Vargas F; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2003; 68(2):113-9. PubMed ID: 15127647
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease.
Kohata Y; Fujiwara Y; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Tominaga K; Arakawa T
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():36-40. PubMed ID: 25827802
[TBL] [Abstract][Full Text] [Related]
11. Acid reflux episodes sensitize the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease patients.
Emerenziani S; Ribolsi M; Guarino MP; Balestrieri P; Altomare A; Rescio MP; Cicala M
Neurogastroenterol Motil; 2014 Jan; 26(1):108-14. PubMed ID: 24118616
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of symptomatic reflux episodes in Japanese proton pump inhibitor-refractory non-erosive reflux disease patients.
Nakagawa K; Koike T; Iijima K; Saito M; Kikuchi H; Hatta W; Ara N; Uno K; Asano N; Shimosegawa T
World J Gastroenterol; 2015 Dec; 21(47):13352-9. PubMed ID: 26715820
[TBL] [Abstract][Full Text] [Related]
13. Convenient Method of Measuring Baseline Impedance for Distinguishing Patients with Functional Heartburn from those with Proton Pump Inhibitor-Resistant Endoscopic Negative Reflux Disease.
Yoshimine T; Funaki Y; Kawamura Y; Tamura Y; Izawa S; Ebi M; Ogasawara N; Murotani K; Sasaki M; Kasugai K
Digestion; 2019; 99(2):157-165. PubMed ID: 30179879
[TBL] [Abstract][Full Text] [Related]
14. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn.
Frazzoni M; Conigliaro R; Mirante VG; Melotti G
Neurogastroenterol Motil; 2012 Feb; 24(2):141-6, e87. PubMed ID: 21988704
[TBL] [Abstract][Full Text] [Related]
15. Differences Between Patients with Heartburn Refractory to Vonoprazan and Those Refractory to Proton Pump Inhibitors.
Matsumura T; Sonoda M; Okimoto K; Dao HV; Takahashi S; Akizue N; Horio R; Goto C; Kurosugi A; Kaneko T; Ohta Y; Taida T; Kikuchi A; Fujie M; Kato J; Kato N
Dig Dis Sci; 2024 Jun; 69(6):2132-2139. PubMed ID: 38622462
[TBL] [Abstract][Full Text] [Related]
16. Precise role of acid in non-erosive reflux disease.
Wang C; Hunt RH
Digestion; 2008; 78 Suppl 1():31-41. PubMed ID: 18832838
[TBL] [Abstract][Full Text] [Related]
17. The Ameliorating Effect of Switching to Vonoprazan: A Novel Potassium-Competitive Acid Blocker in Patients with Proton Pump Inhibitor Refractory Non-Erosive Reflux Disease.
Abe Y; Koike T; Saito M; Okata T; Nakagawa K; Hatta W; Asanuma K; Uno K; Asano N; Imatani A; Masamune A
Digestion; 2021; 102(3):480-488. PubMed ID: 32062650
[TBL] [Abstract][Full Text] [Related]
18. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
19. Autofluorescence imaging endoscopy can distinguish non-erosive reflux disease from functional heartburn: A pilot study.
Luo X; Guo XX; Wang WF; Peng LH; Yang YS; Uedo N
World J Gastroenterol; 2016 Apr; 22(14):3845-51. PubMed ID: 27076770
[TBL] [Abstract][Full Text] [Related]
20. Ambulatory 24-hour multichannel intraluminal impedance-pH monitoring and high resolution endoscopy distinguish patients with non-erosive reflux disease from those with functional heartburn.
Chu C; Du Q; Li C; Zhang L; Zhou X; Zuo F; Zhang Y; Li F; Xie G; Li Y
PLoS One; 2017; 12(4):e0175263. PubMed ID: 28384225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
